undamentalytics Newsletter
Sign in

Research Frontiers Inc income statement

In fiscal 2025, Research Frontiers Inc reported revenue of $1.1m, down 16.0% on the year before, operating income of −$2.1m (a -190.2% margin) and net income of −$2.0m, or −$0.06 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,5992,0071,2361,5091,4891,5648281,2635409101,3361,121654
Research and development1,6221,5881,4188008631,036628580609583570609551
General and administrative4,4264,7424,0863,128—————————
Operating income−4,449−4,323−4,268−2,419−2,418−3,149−2,577−1,839−2,625−2,033−1,442−2,132−2,278
Income before tax−4,414————————————
Net income−4,414−4,280−4,238−2,414−2,686−3,809−2,341−1,846−2,669−1,908−1,311−2,046−2,250
Diluted EPS−$0.19−$0.18−$0.18−$0.10−$0.10−$0.13−$0.07−$0.06−$0.08−$0.06−$0.04−$0.06−$0.07
Diluted shares (average)24m24m24m24m26m30m31m32m32m33m34m34m34m
EBITDA−4,417−4,183−4,079−2,243−2,237−2,954−2,510−1,809−2,596−2,019−1,427−2,121−2,271

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CITR vs REFRREFR vs SNESBYAH vs REFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Research Frontiers Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Research Frontiers Inc.